The global market for energy-based aesthetic devices is expected to grow from $8.5 billion in 2026 to nearly $29.4 billion by 2036, according to a new report from research firm Market Decipher.
The projected 13.2% annual growth reflects a broader shift toward non-invasive aesthetic treatments that deliver noticeable results with minimal downtime.
The United States remains the world's largest market for such devices, the study says, driven by a mature aesthetics industry, widespread consumer acceptance of cosmetic treatments, and a strong cash-pay healthcare model.
The U.S. market is forecast to grow from $2.7 billion in 2026 to $8.9 billion by 2036 — a 12.5% compound annual growth rate.
For the U.S. spa and medical spa industry, this growth signals where patient demand and business investment are headed. Energy-based technologies, including lasers, radiofrequency (RF), intense pulsed light (IPL), and ultrasound, have become foundational tools for treating concerns such as skin rejuvenation, body contouring, pigmentation, and skin tightening.
One of the biggest emerging opportunities is the growing number of patients using GLP-1 weight-loss medications such as Wegovy, Zepbound, and Ozempic. Significant weight loss can leave patients with loose skin, facial volume loss, and other skin laxity concerns well suited to energy-based treatments.
The report estimates this demographic alone, which didn't exist a few years ago, could represent a $2 billion procedure opportunity by 2030.
The study also highlights continued private equity investment in medspas and dermatology practices. Larger organizations often have the resources to invest in advanced technology that expands treatment options, improves patient retention, and supports long-term growth.